AstraZeneca has been approached a couple of times by Chinese authorities about their investigation into the drugmaker's ...

Strong results from AstraZeneca helped London's blue-chip index notch a record close on Thursday, while a dovish majority ...

You may not have heard of Ansys, but it's in the process of being acquired by chip design tool firm Synopsys for $35 billion.

Over at CES 2023, Luke swung by to see AMD's exhibition. He gets a look at some new Ryzen 7000 laptops, and also gives his thoughts on the newly-announced 3D V-Cache CPUs. Could this be AMD's year?

The company said, “In relation to the illegal drug importation allegations, in January 2025, AstraZeneca (AZN) received a Notice of Transfer to ...

AstraZeneca has abandoned a £450m investment in a major UK vaccine plant just days after Rachel Reeves vowed to “kick-start economic growth”. The drugmaker, which is Britain’s most valuable ...

UK drugmaker AstraZeneca overcame a drop in sales in China and the arrest of its top executive in the country to deliver an 18 per cent increase in revenues in the final quarter of 2024.

In substance and timing, AstraZeneca's decision to cancel a planned expansion of its flu vaccine facility at Speke is a blow to the government's recent zeal for growth. Instead of injecting £450m ...

AstraZeneca has cancelled plans for a £450m vaccine manufacturing plant in Liverpool, blaming a cut in funding from government. The investment, announced last year in the Tories' spring budget ...

AstraZeneca has warned it could face a fine in China over possible unpaid import taxes, as it revealed strong sales of cancer drugs helped lift revenues higher. The FTSE 100-listed drugmaker said ...

The government has defended its negotiations with AstraZeneca, after the pharmaceutical giant ditched a planned £450m investment last week, blaming a shortfall in government funding. Science ...